 RELIEF THERAPEUTICS Holding AG SIX: RLF Relief, together with NeuroRx, a Delaware Corporation. have filed an Investigational New Drug IND Application with the US FDA for a phase 2 trial of RLF-100 Aviptadil in the treatment of Acute and Moderate Respiratory Distress in patients infected 